CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
CANADA
  • US
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Different Types of Clinical Trial Recruitment Strategies

Different Types of Clinical Trial...

Clinically Media's Ceo Named One Of The Most Influential People In Healthcare Today

Clinically Media's Ceo Named One Of...

Role of Decentralized Clinical Trials in Patient Recruitment

Role of Decentralized Clinical Trials...

How to Use Clinical Trial Matching Software for The Trials?

How to Use Clinical Trial Matching...

Advanced HPV-16 Positive Head and Neck Cancer: PDS Biotech Enlists First Stage of Checkpoint Inhibitor Nave Patients

Advanced HPV-16 Positive Head and...

StudyKIK Acquired by Syneos Health to Deliver Patient and Physician Benefits

StudyKIK Acquired by Syneos Health to...

Syneos Health Partners with Ride Health

Syneos Health Partners with Ride Health

How Patient Recruitment Technologies Can Enhance Clinical Trials

How Patient Recruitment Technologies...

Different Types of Clinical Trial Recruitment Strategies

Different Types of Clinical Trial...

Clinically Media's Ceo Named One Of The Most Influential People In Healthcare Today

Clinically Media's Ceo Named One Of...

Role of Decentralized Clinical Trials in Patient Recruitment

Role of Decentralized Clinical Trials...

How to Use Clinical Trial Matching Software for The Trials?

How to Use Clinical Trial Matching...

Advanced HPV-16 Positive Head and Neck Cancer: PDS Biotech Enlists First Stage of Checkpoint Inhibitor Nave Patients

Advanced HPV-16 Positive Head and...

StudyKIK Acquired by Syneos Health to Deliver Patient and Physician Benefits

StudyKIK Acquired by Syneos Health to...

Syneos Health Partners with Ride Health

Syneos Health Partners with Ride Health

How Patient Recruitment Technologies Can Enhance Clinical Trials

How Patient Recruitment Technologies...

Why it is Necessary to Accelerate the Clinical Trial Patient Recruitment Process

Life Sciences Review | Wednesday, July 21, 2021
Tweet

Clinical trial patient recruitment can be difficult, but it is essential to accelerate the process so that new medicines can enter the market as soon as possible. 


FREMONT, CA: One of the most challenging aspects of medical research nowadays is the speed as patients need new therapies immediately once, yet clinical studies are frequently delayed or shut down owing to a lack of individuals willing to participate.


Sponsors can meet and beat deadlines by recruiting patients for clinical trials and quickly bring novel treatments to patients. Patients worldwide seek medicines that will be better than their present options and cure their health conditions.


If the patient recruitment process for clinical trials is faster, the entire drug development process can also be done quickly. For example, a new medicine takes typically at least ten years to reach the market, with clinical trials accounting for more than half of that period (six to seven years). When that period is shortened, much-needed medicines can reach patients sooner.


It can be difficult to envision the benefits of increasing patient recruitment in a setting where even achieving stated deadlines would be a welcome shift. Here are some of the most compelling reasons to focus on accelerating patient recruiting


Save on operational cost


Running a clinical trial is a vast, enormous investment, and patient recruitment is a challenge in itself. But once patients are enrolled in a study, many people and resources are engaged in guaranteeing that the survey has appropriate sites, that the investigational medication is administered correctly, the patients are immediately 


followed, and the data is securely collected. It is also necessary to ensure all procedures are followed in producing and presenting an NDA to the FDA.


Improve sponsor's reputation


Trial sponsors are frequently required to report their medical study status to boards, investors, or shareholders. One method to ensure that the sponsor maintains support for the trial and even improves their reputation in front of the key stakeholders is to speed up recruiting and enrolment.


Move on more quickly


People know that clinical studies don't always result in a successful treatment. According to a survey, the average chance of FDA approval from Phase 1 was 9.6 percent, or one in ten, and this percentage is much lower in particularly complex diseases like cancer.


Once treatment has progressed to Phase 2, the chances of advancing to Phase 3 remain low, with less than a third of investigational treatments moving to this stage. This is the nature of clinical trials, but the difficulty is that finding patients for the trials might take years and determining that an investigational treatment doesn't work as expected can take even longer.


See Also: Top 10 Data Center Consulting/Implementation Services Companies In APAC - 2020


Weekly Brief

loading
Top 10 Patient Recruitment Solutions Companies - 2022
> <
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue

Read Also

Prophesying DNA Sequencing for 2023

Crucial Workflows of Next-Generation Sequencing

An Overview of Next-Generation Sequencing

The Role of AI in Accurate Medical Writing

Patrik Renblad to Join Cantargia as Chief Financial Officer

Overview of the Life Sciences BPO Market

Dr. Zamaneh Mikhak Joins TFF Pharmaceutical as the New Chief Medical Officer

The Significance of AI in Medical Writing

Loading...

Copyright © 2023 Life Sciences Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/why-it-is-necessary-to-accelerate-the-clinical-trial-patient-recruitment-process--nwid-394.html